Hualan Biological Bacterin Inc. Price (301207.SZ)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

602,429,841

(0.4025)%

Income Statement Summary

Revenue
Cost of Revenue
Gross Profit
Operating Expenses
Operating Income
Other Expenses
Net Income
news-img
Hualan Biological Bacterin Inc.
news-img

Income Statement

Hualan Biological Bacterin Inc.

Currency: CNY

YEAR 2017 2018 2019 2020 2021 2022 2023
Revenue
Revenue 284,911,448.00

+0%

802,738,151.00

+182%

1,048,988,237.00

+31%

2,426,328,945.00

+131%

1,829,813,885.00

-25%

1,825,640,965.00

0%

2,410,428,457.00

+32%

Cost of Revenue
Cost of Revenue 87,853,968.00 126,873,132.00 161,005,995.00 257,939,198.00 220,760,728.00 217,451,485.00 287,097,741.00
Gross Profit
Gross Profit 197,057,480.00

+0%

675,865,019.00

+243%

887,982,242.00

+31%

2,168,389,747.00

+144%

1,609,053,157.00

-26%

1,608,189,480.00

0%

2,123,330,716.00

+32%

Gross Profit Ratio (0.69%) (0.84%) (0.85%) (0.89%) (0.88%) (0.88%) (0.88%)
Operating Expenses
Research and Development 64,021,137.00 52,976,547.00 73,042,003.00 110,937,486.00 144,128,186.00 134,639,873.00 91,108,469.00
General and Administrative 1,446,169.00 -81,566,201.20 -89,235,773.41 -83,103,396.01 25,648,012.00 9,315,699.00 11,490,099.00
Selling, General & Admin... 189,247,520.00 255,775,165.00 216,850,188.00 782,153,552.00 608,616,394.00 689,949,745.00 952,784,623.00
Selling & Marketing Exp... 187,801,351.00 337,341,366.00 306,085,961.00 865,256,948.00 582,968,382.00 680,634,046.00 941,294,524.00
Depreciation and Amortiz... 33,800,122.00 4,904,700.00 11,968,900.00 40,845,329.00 70,475,463.00 141,582,388.00 140,328,627.00
Other Expenses 968,004.00 932,238.00 -1,270,119.13 1,907,935.00 -1,226,781.42 -3,155,095.87 69,380,370.00
Total Operating Expenses 265,512,297.00 320,844,628.00 369,091,556.00 1,003,859,806.00 793,886,959.00 855,961,586.00 1,113,273,463.00
Cost and Exponses 353,366,265.00 447,717,760.00 530,097,551.00 1,261,799,004.00 1,014,647,687.00 1,073,413,072.00 1,400,371,204.00
Operating Income
Operating Income -100,525,435.51

+0%

299,801,824.00

-398%

432,041,145.00

+44%

1,074,089,707.00

+149%

706,976,269.00

-34%

592,633,934.00

-16%

1,010,057,252.00

+70%

Operating Income Ratio (-0.35%) (0.37%) (0.41%) (0.44%) (0.39%) (0.32%) (0.42%)
Other Income and Exp...
Interest Income 505,441.00 1,408,207.00 1,776,107.00 5,390,093.00 5,057,662.00 16,411,272.00 11,435,817.00
Interest Expenses 33,468.00 43,615.00 64,845.00 7,986,944.00 13,315,822.00 10,693,071.00 6,187,145.00
Total Other Income/Exp... 19,258,768.00 1,548,131.00 33,453.00 -35,652.00 -1,226,782.00 -3,155,095.00 -3,176,136.00
EBITDA
EBITDA 12,216,807.00 306,254,700.00 444,043,500.00 1,117,127,261.00 789,735,019.00 741,882,852.00 1,157,926,743.00
EBITDA ratio (0.04%) (0.56%) (0.62%) (0.50%) (0.50%) (0.52%) (0.48%)
Income Before Tax
Income Before Tax -99,557,431.44 301,349,955.00 432,074,598.00 1,074,054,055.00 705,749,487.00 589,478,839.00 1,006,881,116.00
Income Before Tax Ratio (-0.35%) (0.38%) (0.41%) (0.44%) (0.39%) (0.32%) (0.42%)
Income Tax Expense
Income Tax Expense -22,675,854.69 31,202,137.00 56,776,879.00 149,144,925.00 84,777,072.00 69,844,034.00 146,912,518.00
Net Income
Net Income -76,881,576.75

+0%

270,147,818.00

-451%

375,297,719.00

+39%

924,909,129.00

+146%

620,972,414.00

-33%

519,634,804.00

-16%

859,968,598.00

+65%

Net Income Ratio (-0.27%) (0.34%) (0.36%) (0.38%) (0.34%) (0.28%) (0.36%)
Earning Per Share
Basic EPS -0.14 0.50 0.63 1.54 1.03 0.87 1.43
Diluted EPS -0.14 0.50 0.63 1.54 1.03 0.87 1.43
Share Outstanding
Basic Share Outstanding 539,898,713.00 540,007,632.00 600,015,060.00 600,015,060.00 600,015,060.00 600,015,060.00 600,704,525.00
Diluted Share Outstanding 539,898,713.00 540,007,632.00 600,015,060.00 600,015,060.00 600,015,060.00 600,015,060.00 602,429,841.00
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation